[1]
Joshi, D.K. et al. 2023. In-Vitro Comparative Study of Levocetirizine Dihydrochloride and Montelukast Sodium Release Profiles in Xyzal M Suspension and Other Marketed Syrup Formulations. Journal of Drug Delivery and Therapeutics. 13, 8 (Aug. 2023), 32–44. DOI:https://doi.org/10.22270/jddt.v13i8.6164.